Literature DB >> 11980490

Is the PTPase-vanadate complex a true transition state analogue?

Hua Deng1, Robert Callender, Zhonghui Huang, Zhong-Yin Zhang.   

Abstract

Vanadate can often bind to phosphoryl transfer enzymes to form a trigonal-bipyramidal structure at the active site. The enzyme-vanadate dissociation constants in these enzymes are much lower than those for phosphate. Therefore, enzyme-bound vanadate moieties are often considered as transition state analogues. To test whether the enzyme-vanadate complex is a true transition state analogue beyond the simple geometry and binding affinity arguments and whether the bond orders of the VO bonds in the complex approach those of the PO bonds in the transition state, the binding properties of vanadate in the Yersinia protein-tyrosine phosphatase (PTPase) and its T410A, D356N, W354A, R409K, and D356A mutants have been studied by steady-state kinetic measurements and by difference Raman measurements. The results of the kinetic measurements show no correlation between K(I) and kcat or kcat/K(m) in these mutants. In addition, our analysis of the Raman data shows that the bond order change of the nonbridging V--O bonds in the vanadate complexes does not correlate with the kinetic parameters in a number of PTPase variants as predicted by the transition state binding paradigm. Furthermore, the ionization state of the bound vanadate moiety is not invariant across the PTPase variants studied, and the average bond order of the nonbridging V--O bonds decreased by 0.06-0.07 valence unit in the wild type and all of the mutant PTPases, either in dianionic or in monoanionic form. Thus the complex would resemble an associative transition state, contrary to the previously determined dissociative structure of the transition state. Therefore, it is concluded that vanadate is not a true transition state analogue for the PTPase reactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11980490     DOI: 10.1021/bi016097z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Metavanadate at the active site of the phosphatase VHZ.

Authors:  Vyacheslav I Kuznetsov; Anastassia N Alexandrova; Alvan C Hengge
Journal:  J Am Chem Soc       Date:  2012-08-22       Impact factor: 15.419

Review 2.  Enzyme active site interactions by Raman/FTIR, NMR, and ab initio calculations.

Authors:  Hua Deng
Journal:  Adv Protein Chem Struct Biol       Date:  2013       Impact factor: 3.507

3.  High-resolution analysis of Zn(2+) coordination in the alkaline phosphatase superfamily by EXAFS and x-ray crystallography.

Authors:  Elena Bobyr; Jonathan K Lassila; Helen I Wiersma-Koch; Timothy D Fenn; Jason J Lee; Ivana Nikolic-Hughes; Keith O Hodgson; Douglas C Rees; Britt Hedman; Daniel Herschlag
Journal:  J Mol Biol       Date:  2011-10-28       Impact factor: 5.469

4.  Insights into the reaction of protein-tyrosine phosphatase 1B: crystal structures for transition state analogs of both catalytic steps.

Authors:  Tiago A S Brandão; Alvan C Hengge; Sean J Johnson
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

5.  Residue 182 influences the second step of protein-tyrosine phosphatase-mediated catalysis.

Authors:  Anja K Pedersen; Xiao-Ling Guo; Karin B Møller; Günther H Peters; Henrik S Andersen; Jette S Kastrup; Steen B Mortensen; Lars F Iversen; Zhong-Yin Zhang; Niels Peter H Møller
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

6.  Tungstate as a Transition State Analog for Catalysis by Alkaline Phosphatase.

Authors:  Ariana Peck; Fanny Sunden; Logan D Andrews; Vijay S Pande; Daniel Herschlag
Journal:  J Mol Biol       Date:  2016-05-14       Impact factor: 5.469

Review 7.  Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.

Authors:  Samuel Treviño; Alfonso Díaz; Eduardo Sánchez-Lara; Brenda L Sanchez-Gaytan; Jose Manuel Perez-Aguilar; Enrique González-Vergara
Journal:  Biol Trace Elem Res       Date:  2018-10-22       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.